该行认为，国际烟草巨头贯彻无烟化战略，菲莫Q1取得强劲开局，HNB增长符合预期、美国市场有序 推进，看好新型烟草供应链核心标的思摩尔国际。其中HNB 市场潜力仍然较大，且HNB较雾化烟在监 管上更占优(对青少年低吸引力、减害性更易论证)，竞争格局更好(参与厂商少)，同时英美烟草的新一 代Glo Hilo产品无论横向对比市面上的领军产品IQOS iluma i或是纵向对比上一代老产品均有显著的性能 和使用体验提升，看好其在25-26年逐渐拓展至更多市场、迎来放量，思摩尔做为GLO HILO核心供应 商，有望受益。 智通财经APP获悉，思摩尔国际(06969)涨超3%，截至发稿，涨2.36%，报13港元，成交额7316.81万港 元。 浙商证券发布研报称，4月23日，菲莫国际发布2025Q1业绩，IQOS作为HNB市场份额70%+的领军产 品，从其经营表现感知行业成长，对思摩尔的HNB业务潜力具备指导意义。25Q1菲莫国际SFP(Smoke- Free Products)收入同比+20.4%，毛利同比+33.1%，毛利率超过70%、同比提高6.7pct，且比传统烟高出 5pct；出货量同比+14.4%，其中HNB ...

证券研究报告 | 公司点评 | 家居用品 思摩尔国际(06969) 报告日期：2025 年 04 月 24 日 菲莫一季报再次印证新型烟草大势，持续布局 ——思摩尔国际点评报告 投资要点 ❑ 事件：4.23 菲莫国际发布 2025Q1 业绩，IQOS 作为 HNB 市场份额 70%+的领军 产品，从其经营表现感知行业成长，对思摩尔的 HNB 业务潜力具备指导意义。 3）美国 HNB 市场即将打开：美国市场 3 月底在德州试销收到了强烈的市场反 馈，未来几个月进行更多的试点。 4）对 25 年 IQOS 的指引：维持此前 25 全年烟支销量同比增长 10-12%（24 年达 到 1400 亿支、同比+11.6%）的指引，管理层预计今年剩余时间 IQOS 将保持双 位数增长。 5）菲莫 HNB 烟弹 25Q1 在全球市场的份额为 5.7%（同比+0.6pct），在日本市 场达到 32.2%（24Q4 为 30.6%） ❑ 新型口含烟 ZYN 表现亮眼，雾化电子烟开始起量，稳步迈向"无烟气未来" 1）新型口含烟：尼古丁袋 ZYN 在美国 25Q1 出货量 2.02 亿罐（同比+53%）， 在美国以外的国际市场同样取 ...

SMOORE INTERNATIONAL HOLDINGS LIMITED （於開曼群島註冊成立的有限公司） （股份代號：6969） 思摩爾國際控股有限公 司 年報 2024 ANNUAL REPORT 2024 SMOORE INTERNATIONAL HOLDINGS LIMITED 思摩爾國際控股有限公司 Annual Report 2024 年報 非執行董事 (Incorporated in the Cayman Islands with limited liability) (Stock code: 6969) SMOORE INTERNATIONAL HOLDINGS LIMITED 思摩爾國際控股有限公 司 目錄 | 2 | 公司信息 | | --- | --- | | 4 | 財務摘要 | | 6 | 主席報告 | | 10 | 管理層討論與分析 | | 36 | 持續關連交易 | | 38 | 企業管治報告 | | 54 | 董事會報告 | | 86 | 獨立核數師報告 | | 91 | 綜合損益及其他全面收益表 | | 92 | 綜合財務狀況表 | | 94 | 綜合權益變動表 | | 9 ...

证券研究报告 思摩尔国际 (6969 HK) 港股通 看好雾化主业修复，HNB 成长可期 | 华泰研究 | | | 公告点评 | | --- | --- | --- | --- | | 2025 年 | 4 月 | 08 日│中国香港 | 消费轻工 | 风险提示：行业政策收紧，需求不及预期，新业务不及预期，关税加征风险。 经营预测指标与估值 | 会计年度 | 2023 | 2024 | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 营业收入 (人民币百万) | 11,203 | 11,799 | 12,958 | 14,939 | 17,124 | | +/-% | (7.75) | 5.31 | 9.82 | 15.29 | 14.63 | | 归属母公司净利润 (人民币百万) | 1,645 | 1,303 | 1,323 | 2,140 | 2,762 | | +/-% | (34.47) | (20.78) | 1.54 | 61.71 | 29.08 | | EPS (人民币，最新摊薄) | 0.27 | 0.21 | ...

Investment Rating - The report maintains a "Buy" rating for the company, expecting a price increase of over 15% in the next 6-12 months [4]. Core Insights - The company reported a significant decline in profits for Q1 2025, with pre-tax and post-tax profits of 260 million and 190 million CNY, respectively, representing year-on-year decreases of 36.3% and 43.4% [2]. - The overseas compliance trend is improving, and the proprietary brand business is expected to continue performing well, driven by stricter regulations on illegal vaping products and market expansion [2][4]. - Increased marketing investments in proprietary brand business and rising stock incentive amortization and R&D expenses are impacting short-term profit performance, but the long-term outlook remains positive [3][4]. Financial Performance Summary - For 2025-2027, the expected EPS is 0.20, 0.40, and 0.56 CNY, with corresponding PE ratios of 46, 23, and 17 times [4]. - Revenue projections show a growth trajectory from 11,168 million CNY in 2023 to 19,489 million CNY by 2027, with a compound annual growth rate (CAGR) of approximately 20.45% [7]. - The net profit is expected to recover from 1,303 million CNY in 2024 to 3,451 million CNY in 2027, indicating a strong rebound in profitability [7].

Investment Rating - The report maintains a "Buy" rating for the company, expecting a price increase of over 15% in the next 6-12 months [4]. Core Views - The company reported a significant decline in profits for Q1 2025, with pre-tax and post-tax profits of 260 million and 190 million CNY, respectively, representing year-on-year decreases of 36.3% and 43.4% [2]. - The overseas compliance trend is improving, and the proprietary brand business is expected to continue performing well. The revenue is anticipated to grow due to stricter regulations on illegal vaping products and the expansion of the compliant market [2]. - Increased marketing investments in proprietary brand business and rising stock incentive amortization and R&D expenses are impacting short-term profit performance, but the overall profit impact is seen as temporary [3]. - The company is rationally addressing tariff impacts on its HNB (Heat-not-Burn) business, with a focus on markets in Japan and Europe, while the growth logic for HNB remains unchanged [4]. Financial Performance Summary - The company’s revenue for 2023 was 11,168 million CNY, with a projected growth rate of -8.04% for 2024, followed by a recovery with growth rates of 10.79%, 23.78%, and 20.45% for 2025, 2026, and 2027, respectively [7]. - The net profit attributable to the parent company for 2023 was 1,645 million CNY, with a significant decline of 34.47% expected in 2024, followed by a gradual recovery [7]. - The diluted EPS is projected to be 0.20, 0.40, and 0.56 CNY for 2025, 2026, and 2027, respectively, with corresponding P/E ratios of 46, 23, and 17 [4][7].

Investment Rating - The report does not provide a specific investment rating for the company [1] Core Views - The company has shown steady growth in its vaping segment, while the future of Heat-Not-Burn (HNB) products looks promising, although increased expenditure is impacting short-term profitability [1][2] - The company is expected to face challenges with disposable products due to tightening regulations in various countries, but there is potential for growth in the APV and HNB segments [2][3] - The U.S. market is crucial for the company, with expectations for the launch of new HNB products, which could enhance market share and revenue [3] Financial Performance Summary - In Q1 2025, the company reported a net profit of 192 million yuan, a decrease of 43.4% year-on-year, with total comprehensive income of 208 million yuan, down 32.9% year-on-year [1] - Revenue for 2024 is projected at 11.799 billion yuan, with a growth rate of 6%, and net profit expected to be 1.303 billion yuan, reflecting a decline of 21% year-on-year [5][6] - The company’s adjusted net profit forecasts for 2025, 2026, and 2027 are 1.411 billion yuan, 2.337 billion yuan, and 3.032 billion yuan, respectively, with corresponding P/E ratios of 39.9X, 24.1X, and 18.6X [4][5] Market and Product Insights - The company is positioned as a key supplier for British American Tobacco, which is expanding its HNB product offerings in various markets, including the U.S. [3] - The anticipated launch of the IQOS ILUMA in the U.S. is expected to further pressure traditional cigarette sales, leading to increased focus on HNB product development [3] - The company is expected to benefit from its unique production capabilities and technology, which may help mitigate tariff pressures in the U.S. market [4]

Investment Rating - The report does not provide a specific investment rating for the company [1] Core Views - The company is experiencing steady growth in its vaping segment, while the future of Heat-Not-Burn (HNB) products looks promising, although increased expenses are impacting short-term profitability [1] - The company reported a net profit of 192 million yuan for Q1 2025, a decrease of 43.4% year-on-year, with total comprehensive income of 208 million yuan, down 32.9% year-on-year [1] - The report anticipates a stable revenue stream for Q1, with profit pressure primarily due to increased expenses and a higher tax rate compared to the previous year [1] Summary by Sections Market Environment - The report highlights regulatory changes affecting disposable vaping products in Belgium, France, and the UK, which are expected to pressure the company's performance in this segment [2] - The company is expected to see a recovery in its APV and refillable products overseas, with a trend of year-on-year improvement anticipated [2] HNB Product Development - The company is positioned to benefit from the expansion of HNB products in the US market, with expectations for the launch of new products by PMI [3] - The report notes that the US market is crucial for the company, with projected revenue and adjusted operating profit contributions of 44% and 54%, respectively [3] Financial Projections - The company is projected to achieve adjusted net profits of 1.41 billion yuan in 2025, 2.34 billion yuan in 2026, and 3.03 billion yuan in 2027, with corresponding P/E ratios of 39.9X, 24.1X, and 18.6X [4] - Total revenue is expected to grow from 11.8 billion yuan in 2024 to 17.1 billion yuan in 2027, with a compound annual growth rate of approximately 23% [5] - The report outlines a decrease in net profit for 2024, followed by a recovery in subsequent years, with growth rates of 8% in 2025 and 66% in 2026 [5][7] Key Financial Metrics - The company’s total assets are projected to increase from 27.65 billion yuan in 2024 to 35.85 billion yuan in 2027, indicating a strong growth trajectory [6][7] - The report provides detailed financial metrics, including operating income, net profit, and earnings per share (EPS), with EPS expected to rise from 0.21 yuan in 2024 to 0.49 yuan in 2027 [5][6]

证券研究报告 公司研究 [Table_ReportType] 公司点评报告 | [Table_StockAndRank] 思摩尔国际(6969.HK) | | | --- | --- | | 投资评级 | 无评级 | | 上次评级 | 无评级 | [Table_Author] 姜文镪 新消费行业首席分析师 执业编号：S1500524120004 邮箱：jiangwenqiang@cindasc.com 信达证券股份有限公司 CINDA SECURITIES CO.,LTD 北京市西城区宣武门西大街甲127号金隅大厦B 座 邮编：100031 [Table_Title] 思摩尔国际：英美扩张节奏清晰，核心供应商 地位牢固 [Table_OtherReport] [Table_ReportDate] 2025 年 3 月 31 日 [Table_S 近期走访大量 ummary]HNB 企业，从业者对思摩尔 HNB 创新表现振奋。尽管市场 对英美推广节奏及思摩尔供应地位尚有疑虑，但根据我们跟踪，HNB 产业 链条长、从业企业主要聚焦细分领域，能一体化设计研发的企业少之又少， 加热技术、烟支结构、烟芯发烟、设备设计等 ...

事项： 证 券 研 究 报 告 思摩尔国际（06969.HK）2024 年报点评 强推（维持） 自有品牌增长亮眼，HNB 成长可期 公司公布 2024 年业绩公告。2024 年公司实现收入 117.99 亿元，同比+5.6%； 归母净利润为 13.03 亿元，同比-20.8%。 评论： [ReportFinancialIndex] 主要财务指标 | | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | | 营业总收入(百万) | 11,799 | 12,944 | 14,876 | 16,832 | | 同比增速(%) | 5.6% | 9.7% | 14.9% | 13.1% | | 归母净利润(百万) | 1,303 | 1,514 | 2,029 | 2,455 | | 同比增速(%) | -20.8% | 16.2% | 34.0% | 21.0% | | 每股盈利(元) | 0.21 | 0.25 | 0.33 | 0.40 | | 市盈率(倍) | 59.2 | 50.9 | 38.0 | 31.4 | | 市净率(倍) ...